Grantham, Mayo, Van Otterloo & Co (GMO)’s iShares MSCI Emerging Markets ex China ETF EMXC Stock Holding History
Bought
Maintained
Sold
Other funds holding EMXC
Grantham, Mayo, Van Otterloo & Co (GMO)'s EMXC Position: Q3 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its iShares MSCI Emerging Markets ex China ETF (EMXC) stake by 20% in Q3 2026, buying an estimated $227K and bringing the position to 14,292 shares worth $1.42M. The position accounts for ﹤0.01% of the portfolio, ranked #492.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in EMXC in Q3 2024 and has held it in 6 quarters since. The position peaked at $6.13M in Q3 2024. 1,019 funds tracked by Wall St. Rank hold EMXC as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 14,292 shares of iShares MSCI Emerging Markets ex China ETF worth $1.42M as of Q3 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 2,345 iShares MSCI Emerging Markets ex China ETF shares in Q3 2026, an estimated $227K.
- iShares MSCI Emerging Markets ex China ETF made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #492 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in iShares MSCI Emerging Markets ex China ETF in Q3 2024 and has held it in 6 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s iShares MSCI Emerging Markets ex China ETF position peaked at $6.13M in Q3 2024.
- 1,019 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ex China ETF as of Q3 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.